Francesco Pezzella - Publications

Affiliations: 
University of Oxford, Oxford, United Kingdom 

71/179 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Frei AL, McGuigan A, Sinha RRAK, Jabbar F, Gneo L, Tomasevic T, Harkin A, Iveson T, Saunders MP, Oien KA, Maka N, Pezzella F, Campo L, Browne M, Glaire M, et al. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis. The Lancet. Oncology. 25: 198-211. PMID 38301689 DOI: 10.1016/S1470-2045(23)00560-0  0.561
2022 Ribatti D, Pezzella F. Vascular Co-Option and Other Alternative Modalities of Growth of Tumor Vasculature in Glioblastoma. Frontiers in Oncology. 12: 874554. PMID 35433447 DOI: 10.3389/fonc.2022.874554  0.3
2021 Fanfani V, Citi L, Harris AL, Pezzella F, Stracquadanio G. The landscape of the heritable cancer genome. Cancer Research. PMID 33731442 DOI: 10.1158/0008-5472.CAN-20-3348  0.342
2020 Fanfani V, Zatopkova M, Harris AL, Pezzella F, Stracquadanio G. Dissecting the heritable risk of breast cancer: from statistical methods to susceptibility genes. Seminars in Cancer Biology. PMID 32569822 DOI: 10.1016/j.semcancer.2020.06.001  0.353
2018 Donnem T, Reynolds AR, Kuczynski EA, Gatter K, Vermeulen PB, Kerbel RS, Harris AL, Pezzella F. Non-angiogenic tumours and their influence on cancer biology. Nature Reviews. Cancer. PMID 29520090 DOI: 10.1038/Nrc.2018.14  0.43
2017 Suh YE, Lawler K, Henley-Smith R, Pike L, Leek R, Barrington S, Odell EW, Ng T, Pezzella F, Guerrero-Urbano T, Tavassoli M. Association between hypoxic volume and underlying hypoxia-induced gene expression in oropharyngeal squamous cell carcinoma. British Journal of Cancer. PMID 28324887 DOI: 10.1038/bjc.2017.66  0.617
2016 Adighibe O, Leek RD, Fernandez-Mercado M, Hu J, Snell C, Gatter KC, Harris AL, Pezzella F. Why some tumours trigger neovascularisation and others don't: the story thus far. Chinese Journal of Cancer. 35: 18. PMID 26873439 DOI: 10.1186/s40880-016-0082-6  0.781
2016 Tan K, Haider S, Zois C, Turley H, Leek R, Harris A, Buffa F, Acuto O, Pezzella F. NUB1 protein regulates cullins and E3 ligases in estrogen receptor negative breast cancers European Journal of Cancer. 61: S190. DOI: 10.1016/S0959-8049(16)61672-6  0.696
2015 Pezzella F, Harris AL, Tavassoli M, Gatter KC. Blood vessels and cancer much more than just angiogenesis. Cell Death Discovery. 1: 15064. PMID 27551488 DOI: 10.1038/cddiscovery.2015.64  0.374
2014 Kato T, Pezzella F, Steers G, Campo L, Leek RD, Turley H, Kameoka S, Nishikawa T, Harris AL, Gatter KC, Fox S. Blood vessel invasion and other variables as predictors of long-term survival in Japanese and British patients with primary invasive breast cancer. International Journal of Clinical and Experimental Pathology. 7: 7967-78. PMID 25550840  0.778
2014 Adighibe O, Turley H, Leek R, Harris A, Coutts AS, La Thangue N, Gatter K, Pezzella F. JMY protein, a regulator of P53 and cytoplasmic actin filaments, is expressed in normal and neoplastic tissues. Virchows Archiv : An International Journal of Pathology. 465: 715-22. PMID 25280461 DOI: 10.1007/s00428-014-1660-0  0.778
2014 Pezzella F, Harris AL. When cancer co-opts the vasculature. The New England Journal of Medicine. 370: 2146-7. PMID 24869725 DOI: 10.1056/NEJMcibr1402407  0.344
2014 Agorreta J, Hu J, Liu D, Delia D, Turley H, Ferguson DJ, Iborra F, Pajares MJ, Larrayoz M, Zudaire I, Pio R, Montuenga LM, Harris AL, Gatter K, Pezzella F. TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC. Molecular Cancer Research : McR. 12: 660-9. PMID 24567527 DOI: 10.1158/1541-7786.MCR-13-0481  0.642
2014 Snell CE, Turley H, McIntyre A, Li D, Masiero M, Schofield CJ, Gatter KC, Harris AL, Pezzella F. Proline-hydroxylated hypoxia-inducible factor 1α (HIF-1α) upregulation in human tumours. Plos One. 9: e88955. PMID 24563687 DOI: 10.1371/Journal.Pone.0088955  0.805
2014 Abdulla Z, Turley H, Gatter K, Pezzella F. Immunohistological recognition of cyclin D1 expression by non-lymphoid cells among lymphoid neoplastic cells. Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. 122: 183-91. PMID 23758159 DOI: 10.1111/apm.12123  0.558
2014 Snell CE, Turley H, McIntyre A, Li D, Masiero M, Schofield CJ, Gatter KC, Harris AL, Pezzella F. Expression of proline-hydroxylated HIF-1α predicts poorer overall survival in primary breast cancer. Plos One. DOI: 10.1371/Journal.Pone.0088955.G005  0.773
2013 Donnem T, Hu J, Ferguson M, Adighibe O, Snell C, Harris AL, Gatter KC, Pezzella F. Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment? Cancer Medicine. 2: 427-36. PMID 24156015 DOI: 10.1002/cam4.105  0.699
2013 Giatromanolaki A, Koukourakis MI, Pouliliou S, Gatter KC, Pezzella F, Harris AL, Sivridis E. Overexpression of LC3A autophagy protein in follicular and diffuse large B-cell lymphomas. Hematology/Oncology and Stem Cell Therapy. 6: 20-5. PMID 23664601 DOI: 10.1016/j.hemonc.2013.02.001  0.6
2013 Kashima TG, Turley H, Dongre A, Pezzella F, Athanasou NA. Diagnostic utility of aP2/FABP4 expression in soft tissue tumours. Virchows Archiv : An International Journal of Pathology. 462: 465-72. PMID 23511993 DOI: 10.1007/s00428-013-1392-6  0.579
2012 Biswas S, Charlesworth PJ, Turner GD, Leek R, Thamboo PT, Campo L, Turley H, Dildey P, Protheroe A, Cranston D, Gatter KC, Pezzella F, Harris AL. CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC. Carcinogenesis. 33: 1717-25. PMID 22777959 DOI: 10.1093/carcin/bgs222  0.792
2011 Jubb AM, Cesario A, Ferguson M, Congedo MT, Gatter KC, Lococo F, Mulè A, Pezzella F. Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases. British Journal of Cancer. 104: 1877-81. PMID 21540863 DOI: 10.1038/bjc.2011.147  0.665
2010 Biswas S, Troy H, Leek R, Chung YL, Li JL, Raval RR, Turley H, Gatter K, Pezzella F, Griffiths JR, Stubbs M, Harris AL. Effects of HIF-1alpha and HIF2alpha on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 Xenografts. Journal of Oncology. 2010: 757908. PMID 20652061 DOI: 10.1155/2010/757908  0.763
2010 Liu D, Hu J, Agorreta J, Cesario A, Zhang Y, Harris AL, Gatter K, Pezzella F. Tumor necrosis factor receptor-associated protein 1(TRAP1) regulates genes involved in cell cycle and metastases. Cancer Letters. 296: 194-205. PMID 20471161 DOI: 10.1016/j.canlet.2010.04.017  0.427
2009 Jubb AM, Turley H, Moeller HC, Steers G, Han C, Li JL, Leek R, Tan EY, Singh B, Mortensen NJ, Noguera-Troise I, Pezzella F, Gatter KC, Thurston G, Fox SB, et al. Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer. British Journal of Cancer. 101: 1749-57. PMID 19844231 DOI: 10.1038/sj.bjc.6605368  0.824
2009 Turley H, Steers G, Li JL, Sainson R, Harris AL, Pezzella F, Gatter KC. Corrigendum. Histopathology. 55: 463-4. PMID 19817897 DOI: 10.1111/j.1365-2559.2009.03412.x  0.75
2009 Martinez JC, Müller MM, Turley H, Steers G, Choteau L, Li JL, Sainson R, Harris AL, Pezzella F, Gatter KC. Nuclear and membrane expression of the angiogenesis regulator delta-like ligand 4 (DLL4) in normal and malignant human tissues. Histopathology. 54: 598-606. PMID 19413639 DOI: 10.1111/j.1365-2559.2009.03279.x  0.797
2009 Tan EY, Yan M, Campo L, Han C, Takano E, Turley H, Candiloro I, Pezzella F, Gatter KC, Millar EK, O'Toole SA, McNeil CM, Crea P, Segara D, Sutherland RL, et al. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. British Journal of Cancer. 100: 405-11. PMID 19165203 DOI: 10.1038/sj.bjc.6604844  0.744
2008 Giatromanolaki A, Koukourakis MI, Pezzella F, Sivridis E, Turley H, Harris AL, Gatter KC. Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins. Leukemia & Lymphoma. 49: 2181-6. PMID 19021062 DOI: 10.1080/10428190802450629  0.755
2008 Giatromanolaki A, Koukourakis MI, Pezzella F, Sivridis E, Turley H, Harris AL, Gatter KC. Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation. Hematological Oncology. 26: 219-24. PMID 18461646 DOI: 10.1002/hon.861  0.765
2008 Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS, Harris AL. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. British Journal of Haematology. 141: 672-5. PMID 18318758 DOI: 10.1111/j.1365-2141.2008.07077.x  0.378
2008 Giatromanolaki A, Koukourakis MI, Pezzella F, Turley H, Sivridis E, Bouros D, Bougioukas G, Harris AL, Gatter KC. Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway. Cancer Letters. 262: 87-93. PMID 18187257 DOI: 10.1016/j.canlet.2007.11.041  0.741
2007 Tan EY, Campo L, Han C, Turley H, Pezzella F, Gatter KC, Harris AL, Fox SB. Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer. Breast Cancer Research : Bcr. 9: R89. PMID 18096060 DOI: 10.1186/bcr1838  0.767
2007 Kato T, Steers G, Campo L, Roberts H, Leek RD, Turley H, Kimura T, Kameoka S, Nishikawa T, Kobayashi M, Harris AL, Gatter KC, Pezzella F. Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer. British Journal of Cancer. 97: 1277-86. PMID 17923874 DOI: 10.1038/sj.bjc.6604015  0.742
2007 Van den Eynden GG, Colpaert CG, Couvelard A, Pezzella F, Dirix LY, Vermeulen PB, Van Marck EA, Hasebe T. A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation. Histopathology. 51: 440-51. PMID 17593207 DOI: 10.1111/j.1365-2559.2007.02761.x  0.3
2007 Trivella M, Pezzella F, Pastorino U, Harris AL, Altman DG. Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data. The Lancet. Oncology. 8: 488-99. PMID 17513172 DOI: 10.1016/S1470-2045(07)70145-6  0.425
2007 Sington J, Giatromanolaki A, Campo L, Turley H, Pezzella F, Gatter KC. BNIP3 expression in follicular lymphoma. Histopathology. 50: 555-60. PMID 17394490 DOI: 10.1111/j.1365-2559.2007.02657.x  0.578
2007 Tan EY, Campo L, Han C, Turley H, Pezzella F, Gatter KC, Harris AL, Fox SB. BNIP3 as a progression marker in primary human breast cancer; opposing functions in in situ versus invasive cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 467-74. PMID 17255267 DOI: 10.1158/1078-0432.CCR-06-1466  0.752
2006 Adam PJ, Terrett JA, Steers G, Stockwin L, Loader JA, Fletcher GC, Lu LS, Leach BI, Mason S, Stamps AC, Boyd RS, Pezzella F, Gatter KC, Harris AL. CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding. British Journal of Cancer. 95: 298-306. PMID 16892042 DOI: 10.1038/sj.bjc.6603222  0.393
2006 Blazquez C, Cook N, Micklem K, Harris AL, Gatter KC, Pezzella F. Phosphorylated KDR can be located in the nucleus of neoplastic cells. Cell Research. 16: 93-8. PMID 16467880 DOI: 10.1038/sj.cr.7310012  0.391
2005 Kato T, Prevo R, Steers G, Roberts H, Leek RD, Kimura T, Kameoka S, Nishikawa T, Kobayashi M, Jackson DG, Harris AL, Gatter KC, Pezzella F. A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity. British Journal of Cancer. 93: 1168-74. PMID 16251871 DOI: 10.1038/sj.bjc.6602844  0.707
2005 Zhang Y, Pillai G, Gatter K, Blázquez C, Turley H, Pezzella F, Watt SM. Expression and cellular localization of vascular endothelial growth factor A and its receptors in acute and chronic leukemias: an immunohistochemical study. Human Pathology. 36: 797-805. PMID 16084950 DOI: 10.1016/j.humpath.2005.05.015  0.622
2005 Daniels RA, Turley H, Kimberley FC, Liu XS, Mongkolsapaya J, Ch'en P, Xu XN, Jin B, Pezzella F, Screaton GR. Expression of TRAIL and TRAIL receptors in normal and malignant tissues Cell Research. 15: 430-438. PMID 15987601 DOI: 10.1038/sj.cr.7290311  0.619
2005 Couvelard A, O'Toole D, Leek R, Turley H, Sauvanet A, Degott C, Ruszniewski P, Belghiti J, Harris AL, Gatter K, Pezzella F. Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas. Histopathology. 46: 668-76. PMID 15910598 DOI: 10.1111/j.1365-2559.2005.02160.x  0.764
2005 Campo L, Turley H, Han C, Pezzella F, Gatter KC, Harris AL, Fox SB. Angiogenin is up-regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival. The Journal of Pathology. 205: 585-91. PMID 15776477 DOI: 10.1002/path.1740  0.753
2005 Pillai G, Cook N, Turley H, Leek RD, Blasquez C, Pezzella F, Harris AL, Gatter KC. The expression and cellular localization of phosphorylated VEGFR2 in lymphoma and non-neoplastic lymphadenopathy: an immunohistochemical study. Histopathology. 46: 209-16. PMID 15693894 DOI: 10.1111/j.1365-2559.2005.02081.x  0.757
2005 Hu J, Bianchi F, Ferguson M, Cesario A, Margaritora S, Granone P, Goldstraw P, Tetlow M, Ratcliffe C, Nicholson AG, Harris A, Gatter K, Pezzella F. Gene expression signature for angiogenic and nonangiogenic non-small-cell lung cancer. Oncogene. 24: 1212-9. PMID 15592519 DOI: 10.1038/sj.onc.1208242  0.47
2005 Couvelard A, O'Toole D, Turley H, Leek R, Sauvanet A, Degott C, Ruszniewski P, Belghiti J, Harris AL, Gatter K, Pezzella F. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. British Journal of Cancer. 92: 94-101. PMID 15558070 DOI: 10.1038/sj.bjc.6602245  0.796
2004 Stewart M, Turley H, Cook N, Pezzella F, Pillai G, Ogilvie D, Cartlidge S, Paterson D, Copley C, Kendrew J, Barnes C, Harris AL, Gatter KC. The angiogenic receptor KDR is widely distributed in human tissues and tumours and relocates intracellularly on phosphorylation. An immunohistochemical study. Histopathology. 43: 33-9. PMID 12823710 DOI: 10.1046/j.1365-2559.2003.01644.x  0.66
2003 Sardari Nia P, Stessels F, Pezzella F, Vermeulen PB, van Marck EA, van Schil P. Growth index is independent of microvessel density in non-small cell lung carcinomas. Human Pathology. 34: 959-60; author reply. PMID 14562297 DOI: 10.1016/S0046-8177(03)00247-8  0.403
2003 Adam PJ, Berry J, Loader JA, Tyson KL, Craggs G, Smith P, De Belin J, Steers G, Pezzella F, Sachsenmeir KF, Stamps AC, Herath A, Sim E, O'Hare MJ, Harris AL, et al. Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro. Molecular Cancer Research : McR. 1: 826-35. PMID 14517345  0.447
2003 Passalidou E, Stewart M, Trivella M, Steers G, Pillai G, Dogan A, Leigh I, Hatton C, Harris A, Gatter K, Pezzella F. Vascular patterns in reactive lymphoid tissue and in non-Hodgkin's lymphoma. British Journal of Cancer. 88: 553-9. PMID 12592369 DOI: 10.1038/sj.bjc.6600742  0.306
2003 Pelosi G, Pastorino U, Pasini F, Maissoneuve P, Fraggetta F, Iannucci A, Sonzogni A, De Manzoni G, Terzi A, Durante E, Bresaola E, Pezzella F, Viale G. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. British Journal of Cancer. 88: 537-47. PMID 12592367 DOI: 10.1038/sj.bjc.6600731  0.334
2002 Hui EP, Chan AT, Pezzella F, Turley H, To KF, Poon TC, Zee B, Mo F, Teo PM, Huang DP, Gatter KC, Johnson PJ, Harris AL. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 2595-604. PMID 12171890  0.686
2002 Pezzella F, Harris AL, Gatter KC. Ways of escape: are all tumours angiogenic? Histopathology. 39: 551-3. PMID 11903570 DOI: 10.1046/j.1365-2559.2001.01027.x  0.393
2002 Stewart M, Talks K, Leek R, Turley H, Pezzella F, Harris A, Gatter K. Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma. Histopathology. 40: 253-60. PMID 11895491 DOI: 10.1046/j.1365-2559.2002.01357.x  0.813
2002 Leek RD, Talks KL, Pezzella F, Turley H, Campo L, Brown NS, Bicknell R, Taylor M, Gatter KC, Harris AL. Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer. Cancer Research. 62: 1326-9. PMID 11888900  0.807
2002 Passalidou E, Trivella M, Singh N, Ferguson M, Hu J, Cesario A, Granone P, Nicholson AG, Goldstraw P, Ratcliffe C, Tetlow M, Leigh I, Harris AL, Gatter KC, Pezzella F. Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas. British Journal of Cancer. 86: 244-9. PMID 11870514 DOI: 10.1038/sj.bjc.6600015  0.337
2001 Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F, Gatter KC, Harris AL. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. British Journal of Cancer. 85: 881-90. PMID 11556841 DOI: 10.1054/bjoc.2001.2018  0.828
2000 Pruneri G, Bertolini F, Soligo D, Carboni N, Cortelezzi A, Ferrucci PF, Buffa R, Lambertenghi-Deliliers G, Pezzella F. Angiogenesis in myelodysplastic syndromes. British Journal of Cancer. 81: 1398-401. PMID 10604739 DOI: 10.1038/sj.bjc.6693515  0.354
1997 Pezzella F, Di Bacco A, Andreola S, Nicholson AG, Pastorino U, Harris AL. Angiogenesis in primary lung cancer and lung secondaries. European Journal of Cancer (Oxford, England : 1990). 2494-500. PMID 9059338 DOI: 10.1016/S0959-8049(96)00377-2  0.329
1997 Barbareschi M, Caffo O, Veronese S, Leek RD, Fina P, Fox S, Bonzanini M, Girlando S, Morelli L, Eccher C, Pezzella F, Doglioni C, Dalla Palma P, Harris A. Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up. Human Pathology. 27: 1149-55. PMID 8912823 DOI: 10.1016/S0046-8177(96)90307-X  0.71
1996 Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCulloch P, Pezzella F, Viale G, Weidner N, Harris AL, Dirix LY. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. European Journal of Cancer (Oxford, England : 1990). 32: 2474-84. PMID 9059336 DOI: 10.1016/S0959-8049(96)00379-6  0.453
1996 Korkolopoulou P, Kaklamanis L, Pezzella F, Harris AL, Gatter KC. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. British Journal of Cancer. 73: 148-53. PMID 8546899 DOI: 10.1038/bjc.1996.28  0.339
1995 Kocialkowski S, Pezzella F, Morrison H, Jones M, Laha S, Harris AL, Mason DY, Gatter KC. Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphoma. British Journal of Haematology. 89: 55-60. PMID 7833277 DOI: 10.1111/j.1365-2141.1995.tb08911.x  0.371
1995 Caffo O, Barbareschi M, Veronese S, Pezzella F, Leek R, Fox S, Harris A, Dalla Palma P. 686 BCL2 expression in node-negative breast carcinoma: A study on a series of 190 cases with long-term follow-up European Journal of Cancer. 31: S143. DOI: 10.1016/0959-8049(95)95936-Z  0.7
1994 Piris MA, Pezzella F, Martinez-Montero JC, Orradre JL, Villuendas R, Sanchez-Beato M, Cuena R, Cruz MA, Martinez B, Pezella F [corrected to Pezzella F]. p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time. British Journal of Cancer. 69: 337-41. PMID 8297731 DOI: 10.1038/bjc.1994.61  0.322
1994 Leek RD, Kaklamanis L, Pezzella F, Gatter KC, Harris AL. bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. British Journal of Cancer. 69: 135-9. PMID 8286195 DOI: 10.1038/bjc.1994.22  0.698
1994 Pezzella F, Micklem K, Turley H, Pulford K, Jones M, Kocialkowski S, Delia D, Aiello A, Bicknell R, Smith K. Antibody for detecting p53 protein by immunohistochemistry in normal tissues. Journal of Clinical Pathology. 47: 592-6. PMID 8089212 DOI: 10.1136/jcp.47.7.592  0.553
1993 Pezzella F, Morrison H, Jones M, Gatter KC, Lane D, Harris AL, Mason DY. Immunohistochemical detection of p53 and bcl‐2 proteins in non‐Hodgkin's lymphoma Histopathology. 22: 39-44. PMID 8436340 DOI: 10.1111/J.1365-2559.1993.Tb00067.X  0.433
1993 Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Gatter KC, Mason DY. bcl-2 protein in non-small-cell lung carcinoma. The New England Journal of Medicine. 329: 690-4. PMID 8393963 DOI: 10.1056/NEJM199309023291003  0.596
1992 Pezzella F, Turley H, Kuzu I, Gatter KC, Mason DY, Harris A. Reversible p53 expression in lung cancer. Lancet (London, England). 340: 922. PMID 1357342 DOI: 10.1016/0140-6736(92)93342-K  0.575
Low-probability matches (unlikely to be authored by this person)
2015 Pezzella F, Gatter K. Non-angiogenic tumours unveil a new chapter in cancer biology. The Journal of Pathology. 235: 381-3. PMID 25351454 DOI: 10.1002/path.4474  0.283
2021 Ribatti D, Pezzella F. Overview on the Different Patterns of Tumor Vascularization. Cells. 10. PMID 33805699 DOI: 10.3390/cells10030639  0.282
2022 Lugassy C, Vermeulen PB, Ribatti D, Pezzella F, Barnhill RL. Vessel co-option and angiotropic extravascular migratory metastasis: a continuum of tumour growth and spread? British Journal of Cancer. PMID 34987186 DOI: 10.1038/s41416-021-01686-2  0.28
2011 Chi J, Ballabio E, Chen XH, KuÅ¡ec R, Taylor S, Hay D, Tramonti D, Saunders NJ, Littlewood T, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS, Lawrie CH. MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival. Biology Direct. 6: 23. PMID 21592325 DOI: 10.1186/1745-6150-6-23  0.279
2004 Sardari Nia P, Colpaert C, Blyweert B, Kui B, Vermeulen P, Ferguson M, Hendriks J, Weyler J, Pezzella F, Van Marck E, Van Schil P. Prognostic value of nonangiogenic and angiogenic growth patterns in non-small-cell lung cancer. British Journal of Cancer. 91: 1293-300. PMID 15328525 DOI: 10.1038/Sj.Bjc.6602134  0.272
2019 Kuczynski EA, Vermeulen PB, Pezzella F, Kerbel RS, Reynolds AR. Vessel co-option in cancer. Nature Reviews. Clinical Oncology. PMID 30816337 DOI: 10.1038/S41571-019-0181-9  0.264
2012 Haley VL, Barnes DJ, Sandovici I, Constancia M, Graham CF, Pezzella F, Bühnemann C, Carter EJ, Hassan AB. Igf2 pathway dependency of the Trp53 developmental and tumour phenotypes. Embo Molecular Medicine. 4: 705-18. PMID 22674894 DOI: 10.1002/Emmm.201101105  0.258
2018 Adighibe O, Pezzella F. The Role of JMY in p53 Regulation. Cancers. 10. PMID 29857553 DOI: 10.3390/cancers10060173  0.252
2023 Paulsen EE, Andersen S, Rakaee M, Pedersen MI, Lombardi AP, Pøhl M, Kilvaer T, Busund LT, Pezzella F, Donnem T. Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma. Frontiers in Oncology. 13: 1157461. PMID 37182191 DOI: 10.3389/fonc.2023.1157461  0.246
1986 Ruco LP, Pescarmona E, Pezzella F, Uccini S, Testi AM, Cartoni C, Baroni CD. Lectin I of Ulex europaeus as a marker for a subset of histiocytic tumours of the lymph node. Virchows Archiv. a, Pathological Anatomy and Histopathology. 408: 229-40. PMID 3936262 DOI: 10.1007/BF00707985  0.242
2009 Gramley F, Lorenzen J, Knackstedt C, Rana OR, Saygili E, Frechen D, Stanzel S, Pezzella F, Koellensperger E, Weiss C, Münzel T, Schauerte P. Age-related atrial fibrosis. Age (Dordrecht, Netherlands). 31: 27-38. PMID 19234766 DOI: 10.1007/s11357-008-9077-9  0.233
2021 Ribatti D, Solimando AG, Pezzella F. The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer. Cancers. 13. PMID 34298648 DOI: 10.3390/cancers13143433  0.228
1990 Pezzella F, Gatter KC, Mason DY, Bastard C, Duval C, Krajewski A, Turner GE, Ross FM, Clark H, Jones DB. Bcl-2 protein expression in follicular lymphomas in absence of 14;18 translocation. Lancet (London, England). 336: 1510-1. PMID 1979117 DOI: 10.1016/0140-6736(90)93216-c  0.227
1992 Lorenzen J, Hansmann ML, Pezzella F, Hesse C, Kneba M, Gatter KC, Fischer R. Expression of the bcl-2 oncogene product and chromosomal translocation t(14;18) in Hodgkin's disease. Human Pathology. 23: 1205-9. PMID 1427749 DOI: 10.1016/0046-8177(92)90286-C  0.227
2015 Donnem T, Kilvaer TK, Andersen S, Richardsen E, Paulsen E, Hald SM, Al-Saad S, Brustugun OT, Helland A, Lund-Iversen M, Solberg S, Gronberg BH, Wahl SG, Helgeland L, Fløtten O, ... ... Pezzella F, et al. Strategies for clinical implementation of TNM-immunoscore in resected non-small cell lung cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. PMID 26578726 DOI: 10.1093/annonc/mdv560  0.226
1993 Doussis IA, Pezzella F, Lane DP, Gatter KC, Mason DY. An immunocytochemical study of p53 and bcl-2 protein expression in Hodgkin's disease. American Journal of Clinical Pathology. 99: 663-7. PMID 8322700 DOI: 10.1093/Ajcp/99.6.663  0.225
2008 Couvelard A, Deschamps L, Rebours V, Sauvanet A, Gatter K, Pezzella F, Ruszniewski P, Bedossa P. Overexpression of the oxygen sensors PHD-1, PHD-2, PHD-3, and FIH Is associated with tumor aggressiveness in pancreatic endocrine tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 6634-9. PMID 18927305 DOI: 10.1158/1078-0432.CCR-07-5258  0.224
2018 Qian CN, Pezzella F. Tumor vasculature: a sally port for inhibiting cancer cell spreading. Cancer Communications (London, England). 38: 52. PMID 30075743 DOI: 10.1186/s40880-018-0322-z  0.224
1992 Delia D, Aiello A, Soligo D, Fontanella E, Melani C, Pezzella F, Pierotti M, Della Porta G. bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells Blood. 79: 1291-1298. DOI: 10.1182/blood.v79.5.1291.1291  0.221
2023 Pezzella F, Qian CN. Editorial: Vascular co-option and beyond for cancer biology. Frontiers in Oncology. 13: 1227540. PMID 37456261 DOI: 10.3389/fonc.2023.1227540  0.22
1992 Delia D, Aiello A, Soligo D, Fontanella E, Melani C, Pezzella F, Pierotti M, Della Porta G. bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells Blood. 79: 1291-1298. DOI: 10.1182/BLOOD.V79.5.1291.BLOODJOURNAL7951291  0.22
1992 Pezzella F, Jones M, Ralfkiaer E, Ersbøll J, Gatter KC, Mason DY. Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma. British Journal of Cancer. 65: 87-9. PMID 1733447 DOI: 10.1038/bjc.1992.16  0.218
2015 Donnem T, Hald SM, Paulsen EE, Richardsen E, Al-Saad S, Kilvaer TK, Brustugun OT, Helland A, Lund-Iversen M, Poehl M, Olsen KE, Ditzel HJ, Hansen O, Al-Shibli K, Kiselev Y, ... ... Pezzella F, et al. Stromal CD8+ T-cell Density-A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2635-43. PMID 25680376 DOI: 10.1158/1078-0432.CCR-14-1905  0.218
2012 Donnem T, Bremnes RM, Busund LT, Andersen S, Pezzella F. Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer. Journal of Thoracic Disease. 4: 212-3. PMID 22833829 DOI: 10.3978/j.issn.2072-1439.2012.03.02  0.218
1992 Aiello A, Delia D, Borrello MG, Biassoni D, Giardini R, Fontanella E, Pezzella F, Pulford K, Pierotti M, Della Porta G. Flow cytometric detection of the mitochondrial BCL-2 protein in normal and neoplastic human lymphoid cells. Cytometry. 13: 502-9. PMID 1633729 DOI: 10.1002/CYTO.990130509  0.216
2011 Tan EY, Pezzella F, Gatter K. Loss of TRAP1 expression as a possible mechanism behind recurrence risk in advanced breast cancer The Breast. 20: S25. DOI: 10.1016/J.BREAST.2011.08.038  0.215
2000 Passalidou E, Granone P, Pezzella F. Vascular phenotype in non-small cell lung carcinomas Lung Cancer. 29: 181. DOI: 10.1016/S0169-5002(00)80608-X  0.215
2008 Lawrie CH, Shilling R, Troussard X, Cattan H, Mossafa H, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS. Expression profiling of persistent polyclonal B-cell lymphocytosis suggests constitutive expression of the AP-1 transcription complex and downregulation of Fas-apoptotic and TGFbeta signalling pathways. Leukemia. 23: 581-3. PMID 18754033 DOI: 10.1038/leu.2008.223  0.215
2021 Arshad M, Abdul Hamid N, Chan MC, Ismail F, Tan GC, Pezzella F, Tan KL. NUB1 and FAT10 Proteins as Potential Novel Biomarkers in Cancer: A Translational Perspective. Cells. 10. PMID 34571823 DOI: 10.3390/cells10092176  0.214
2016 Tan KL, Pezzella F. Inhibition of NEDD8 and FAT10 ligase activities through the degrading enzyme NEDD8 ultimate buster 1: A potential anticancer approach. Oncology Letters. 12: 4287-4296. PMID 28101194 DOI: 10.3892/ol.2016.5232  0.213
2022 Kovacs I, Bugyik E, Dezso K, Tarnoki-Zach J, Mehes E, Gulyas M, Czirok A, Lang E, Grusch M, Schelch K, Hegedus B, Horvath I, Barany N, Megyesfalvi Z, Tisza A, ... ... Pezzella F, et al. Malignant pleural mesothelioma nodules remodel their surroundings to vascularize and grow. Translational Lung Cancer Research. 11: 991-1008. PMID 35832452 DOI: 10.21037/tlcr-21-828  0.211
2017 Viollet C, Davis DA, Tekeste SS, Reczko M, Ziegelbauer JM, Pezzella F, Ragoussis J, Yarchoan R. RNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature. Plos Pathogens. 13: e1006143. PMID 28046107 DOI: 10.1371/journal.ppat.1006143  0.21
1996 Doussis-Anagnostopoulou I, Remadi S, Kaklamanis L, Pezzella F, Gatter KC. Detection of p53 in Hodgkin's disease using the monoclonal antibody PAb248. The Journal of Pathology. 178: 170-2. PMID 8683384 DOI: 10.1002/(SICI)1096-9896(199602)178:2<170::AID-PATH448>3.0.CO;2-Z  0.21
2009 Lawrie CH, Chi J, Taylor S, Tramonti D, Ballabio E, Palazzo S, Saunders NJ, Pezzella F, Boultwood J, Wainscoat JS, Hatton CSR. Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma. Journal of Cellular and Molecular Medicine. 13: 1248-1260. PMID 19413891 DOI: 10.1111/J.1582-4934.2008.00628.X  0.209
2016 Pezzella F, Gatter K, Qian CN. Twenty years after: the beautiful hypothesis and the ugly facts. Chinese Journal of Cancer. 35: 22. PMID 26911137 DOI: 10.1186/s40880-016-0087-1  0.209
1997 Pastorino U, Andreola S, Tagliabue E, Pezzella F, Incarbone M, Sozzi G, Buyse M, Menard S, Pierotti M, Rilke F. Immunocytochemical markers in stage I lung cancer: relevance to prognosis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 15: 2858-65. PMID 9256129 DOI: 10.1200/JCO.1997.15.8.2858  0.209
2006 Couvelard A, Hu J, Steers G, O'Toole D, Sauvanet A, Belghiti J, Bedossa P, Gatter K, Ruszniewski P, Pezzella F. Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors. Gastroenterology. 131: 1597-610. PMID 17064702 DOI: 10.1053/j.gastro.2006.09.007  0.208
2008 Sardari Nia P, Colpaert C, Vermeulen P, Weyler J, Pezzella F, Van Schil P, Van Marck E. Different growth patterns of non-small cell lung cancer represent distinct biologic subtypes. The Annals of Thoracic Surgery. 85: 395-405. PMID 18222232 DOI: 10.1016/J.Athoracsur.2007.08.054  0.205
2008 Lawrie CH, Saunders NJ, Soneji S, Palazzo S, Dunlop HM, Cooper CDO, Brown PJ, Troussard X, Mossafa H, Enver T, Pezzella F, Boultwood J, Wainscoat JS, Hatton CSR. MicroRNA expression in lymphocyte development and malignancy. Leukemia. 22: 1440-1446. PMID 18185523 DOI: 10.1038/Sj.Leu.2405083  0.205
1999 Aiello A, Du M, Diss TC, Peng H, Pezzella F, Papini D, Giardini R, Pilotti S, Pan L, Isaacson PG. Simultaneous Phenotypically Distinct but Clonally Identical Mucosa-Associated Lymphoid Tissue and Follicular Lymphoma in a Patient With Sjögren’s Syndrome Blood. 94: 2247-2251. DOI: 10.1182/BLOOD.V94.7.2247.419K12_2247_2251  0.204
2010 Ballabio E, Mitchell T, van Kester MS, Taylor S, Dunlop HM, Chi J, Tosi I, Vermeer MH, Tramonti D, Saunders NJ, Boultwood J, Wainscoat JS, Pezzella F, Whittaker SJ, Tensen CP, et al. MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential. Blood. 116: 1105-13. PMID 20448109 DOI: 10.1182/Blood-2009-12-256719  0.204
1999 Pilozzi E, Pulford K, Jones M, Müller-Hermelink HK, Falini B, Ralfkiaer E, Pileri S, Pezzella F, De Wolf-Peeters C, Arber D, Stein H, Mason D, Gatter K. Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma. The Journal of Pathology. 186: 140-3. PMID 9924428 DOI: 10.1002/(SICI)1096-9896(1998100)186:2<140::AID-PATH149>3.0.CO;2-Y  0.202
1997 Villuendas R, Pezzella F, Gatter K, Algara P, Sánchez-Beato M, Martínez P, Martínez JC, Muñoz K, García P, Sánchez L, Kocialkowsky S, Campo E, Orradre JL, Piris MA. p21WAF1/CIP1 AND MDM2 EXPRESSION IN NON‐HODGKIN'S LYMPHOMA AND THEIR RELATIONSHIP TO p53 STATUS: A p53+, MDM2−, p21− IMMUNOPHENOTYPE ASSOCIATED WITH MISSENSE p53 MUTATIONS The Journal of Pathology. 181: 51-61. PMID 9072003 DOI: 10.1002/(Sici)1096-9896(199701)181:1<51::Aid-Path689>3.0.Co;2-N  0.2
2016 Kerr RS, Love S, Segelov E, Johnstone E, Falcon B, Hewett P, Weaver A, Church D, Scudder C, Pearson S, Julier P, Pezzella F, Tomlinson I, Domingo E, Kerr DJ. Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial. The Lancet. Oncology. PMID 27660192 DOI: 10.1016/S1470-2045(16)30172-3  0.188
2001 Zacharatos P, Kotsinas A, Tsantoulis P, Evangelou K, Kletsas D, Asimacopoulos PJ, Doussis-Anagnostopoulou I, Pezzella F, Gatter K, Papavassiliou AG, Kittas C, Gorgoulis VG. Relationship of the K-ras/c-mos Expression Patterns With Angiogenesis in Non-Small Cell Lung Carcinomas Molecular Medicine. 7: 590-597. DOI: 10.1007/BF03401865  0.188
2006 Adighibe O, Micklem K, Campo L, Ferguson M, Harris A, Pozos R, Gatter K, Pezzella F. Is nonangiogenesis a novel pathway for cancer progression? A study using 3-dimensional tumour reconstructions. British Journal of Cancer. 94: 1176-9. PMID 16622442 DOI: 10.1038/sj.bjc.6603039  0.186
2018 Tan K, Pezzella F, Harris A, Acuto O. PO-479 NUB1 as a prognostic marker in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis Esmo Open. 3: A417-A418. DOI: 10.1136/esmoopen-2018-EACR25.982  0.179
1988 Baroni CD, Vitolo D, Remotti D, Biondi A, Pezzella F, Ruco LP, Uccini S. Immunohistochemical heterogeneity of macrophage subpopulations in human lymphoid tissues. Histopathology. 11: 1029-42. PMID 3509750 DOI: 10.1111/j.1365-2559.1987.tb01843.x  0.178
2016 Pezzella F, Gatter KC. Evidence Showing That Tumors Can Grow Without Angiogenesis and Can Switch Between Angiogenic and Nonangiogenic Phenotypes. Journal of the National Cancer Institute. 108. PMID 27059375 DOI: 10.1093/jnci/djw032  0.177
2019 Pezzella F. Early squamous cell lung carcinoma: prognostic biomarkers for the many. Thorax. PMID 31079032 DOI: 10.1136/thoraxjnl-2018-212829  0.175
2003 Pillai G, Roberts H, Gatter K, Pezzella F. p53 expression in normal paraffin-embedded tissue using different antibodies and antigen retrieval buffer systems. Histopathology. 42: 83-7. PMID 12493030 DOI: 10.1046/j.1365-2559.2003.01563.x  0.172
2005 Foster NA, Banerjee AK, Xian J, Roberts I, Pezzella F, Coleman N, Nicholson AG, Goldstraw P, George JP, Rabbitts PH. Somatic genetic changes accompanying lung tumor development. Genes, Chromosomes & Cancer. 44: 65-75. PMID 15937994 DOI: 10.1002/Gcc.20223  0.171
1997 Pezzella F, Andreola S, Nicholson A, Goldstraw P, Pastorino U. 676 Primary and secondary lung carcinomas without neo angiogenesis Lung Cancer. 18: 173. DOI: 10.1016/S0169-5002(97)80056-6  0.169
1998 Nicholson AG, Graham AN, Pezzella F, Agneta G, Goldstraw P, Pastorino U. Does the use of immunohistochemistry to identify micrometastases provide useful information in the staging of node-negative non-small cell lung carcinomas? Lung Cancer (Amsterdam, Netherlands). 18: 231-40. PMID 9444648 DOI: 10.1016/S0169-5002(97)00065-2  0.168
1986 Baroni CD, Pezzella F, Mirolo M, Ruco LP, Rossi GB. Immunohistochemical demonstration of p24 HTLV III major core protein in different cell types within lymph nodes from patients with lymphadenopathy syndrome (LAS). Histopathology. 10: 5-13. PMID 3007320 DOI: 10.1111/j.1365-2559.1986.tb02456.x  0.165
2015 Tan K, Pezzella F. Molecular cochaperone & its deregulation in breast cancer Annals of Oncology. 26: iii31. DOI: 10.1093/ANNONC/MDV121.09  0.163
2007 Jeremy George P, Banerjee AK, Read CA, O'Sullivan C, Falzon M, Pezzella F, Nicholson AG, Shaw P, Laurent G, Rabbitts PH. Surveillance for the detection of early lung cancer in patients with bronchial dysplasia. Thorax. 62: 43-50. PMID 16825337 DOI: 10.1136/thx.2005.052191  0.158
2021 Rakaee M, Kilvaer TK, Jamaly S, Berg T, Paulsen EE, Berglund M, Richardsen E, Andersen S, Al-Saad S, Poehl M, Pezzella F, Kwiatkowski DJ, Bremnes RM, Busund LR, Donnem T. Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer. British Journal of Cancer. PMID 33723388 DOI: 10.1038/s41416-021-01307-y  0.156
1988 Baroni CD, Pescarmona E, Calogero A, Cassano AM, Pezzella F, Barsotti P, Gallo A, Ruco LP. B- and T-cell non-Hodgkin's lymphomas with large multilobated cells: morphological, phenotypic and clinical heterogeneity. Histopathology. 11: 1121-32. PMID 3500905 DOI: 10.1111/j.1365-2559.1987.tb01853.x  0.153
2006 Riegman PH, Oomen MH, Dinjens WN, Oosterhuis JW, Lam KH, Spatz A, Ratcliffe C, Knox K, Mager R, Kerr D, Pezzella F, Van Damme B, Van De Vijver M, Van Boven H, Morente MM, et al. TuBaFrost: European virtual tumor tissue banking. Advances in Experimental Medicine and Biology. 587: 65-74. PMID 17163156  0.145
2009 Fotheringham S, Epping MT, Stimson L, Khan O, Wood V, Pezzella F, Bernards R, La Thangue NB. Genome-wide loss-of-function screen reveals an important role for the proteasome in HDAC inhibitor-induced apoptosis. Cancer Cell. 15: 57-66. PMID 19111881 DOI: 10.1016/j.ccr.2008.12.001  0.145
2022 Pezzella F, Kerbel RS. On coalescent angiogenesis and the remarkable flexibility of blood vessels. Angiogenesis. PMID 34993716 DOI: 10.1007/s10456-021-09825-2  0.143
2017 Pezzella F. Exosomes: recruits for tumour surveillance? Journal of Thoracic Disease. 9: 4295-4299. PMID 29268495 DOI: 10.21037/jtd.2017.10.24  0.143
1994 Bastard C, Deweindt C, Kerckaert J, Lenormand B, Rossi A, Pezzella F, Fruchart C, Duval C, Monconduit M, Tilly H. LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients Blood. 83: 2423-2427. DOI: 10.1182/blood.v83.9.2423.2423  0.141
1994 Bastard C, Deweindt C, Kerckaert J, Lenormand B, Rossi A, Pezzella F, Fruchart C, Duval C, Monconduit M, Tilly H. LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients Blood. 83: 2423-2427. DOI: 10.1182/BLOOD.V83.9.2423.BLOODJOURNAL8392423  0.14
2004 Pillai G, Nicolas M, Lwin K, Pezzella F, Gatter K. An unusual presentation of diffuse tenosynovial giant cell tumour in the neck. Histopathology. 43: 393-6. PMID 14511259 DOI: 10.1046/j.1365-2559.2003.01710.x  0.137
2020 Pezzella F, Ribatti D. Vascular co-option and vasculogenic mimicry mediate resistance to antiangiogenic strategies. Cancer Reports (Hoboken, N.J.). e1318. PMID 33295149 DOI: 10.1002/cnr2.1318  0.136
2021 Trenevska I, Anderson AP, Bentley C, Hassanali T, Wiblin S, Maguire S, Pezzella F, Banham AH, Li D. Comprehensive mutagenesis identifies the peptide repertoire of a p53 T-cell receptor mimic antibody that displays no toxicity in mice transgenic for human HLA-A*0201. Plos One. 16: e0249967. PMID 33836029 DOI: 10.1371/journal.pone.0249967  0.135
2004 Bianchi F, Hu J, Pelosi G, Cirincione R, Ferguson M, Ratcliffe C, Di Fiore PP, Gatter K, Pezzella F, Pastorino U. Lung cancers detected by screening with spiral computed tomography have a malignant phenotype when analyzed by cDNA microarray. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 6023-8. PMID 15447986 DOI: 10.1158/1078-0432.CCR-04-0619  0.134
2006 Riegman PHJ, Dinjens WNM, Oomen MHA, Spatz A, Ratcliffe C, Knox K, Mager R, Kerr D, Pezzella F, van Damme B, van de Vijver M, van Boven H, Morente MM, Alonso S, Kerjaschki D, et al. TuBaFrost 1: Uniting local Frozen Tumour Banks into a European Network: an overview European Journal of Cancer. 42: 2678-2683. PMID 17027254 DOI: 10.1016/j.ejca.2006.04.031  0.133
2003 Pillai G, Lwin K, Pezzella F, Gatter K. Malignant plasmacytosis mimicking erythrophagocytosis. Histopathology. 41: 468-70. PMID 12405915 DOI: 10.1046/j.1365-2559.2002.01505.x  0.13
2015 Hu J, Boeri M, Sozzi G, Liu D, Marchianò A, Roz L, Pelosi G, Gatter K, Pastorino U, Pezzella F. Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk Populations. Ebiomedicine. 2: 829-38. PMID 26425689 DOI: 10.1016/j.ebiom.2015.07.001  0.126
1990 Pezzella F, Ralfkiaer E, Gatter KC, Mason DY. The 14;18 translocation in European cases of follicular lymphoma: comparison of Southern blotting and the polymerase chain reaction. British Journal of Haematology. 76: 58-64. PMID 2223649 DOI: 10.1111/j.1365-2141.1990.tb07836.x  0.125
2007 Borenstein J, Pezzella F, Gatter KC. Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders Histopathology. 51: 774-777. PMID 17944927 DOI: 10.1111/j.1365-2559.2007.02870.x  0.124
2006 Morente MM, Mager R, Alonso S, Pezzella F, Spatz A, Knox K, Kerr D, Dinjens WNM, Oosterhuis JW, Lam KH, Oomen MHA, van Damme B, van de Vijver M, van Boven H, Kerjaschki D, et al. TuBaFrost 2: Standardising tissue collection and quality control procedures for a European virtual frozen tissue bank network European Journal of Cancer. 42: 2684-2691. PMID 17027255 DOI: 10.1016/j.ejca.2006.04.029  0.119
2015 Viollet C, Davis DA, Reczko M, Ziegelbauer JM, Pezzella F, Ragoussis J, Yarchoan R. Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells. Plos One. 10: e0126439. PMID 25942495 DOI: 10.1371/journal.pone.0126439  0.117
2015 Viollet C, Davis DA, Reczko M, Ziegelbauer JM, Pezzella F, Ragoussis J, Yarchoan R. Next-generation sequencing analysis reveals differential expression profiles of miRNA-mRNA target pairs in KSHV-infected cells Plos One. 10. DOI: 10.1371/journal.pone.0126439  0.117
1986 Baroni CD, Pezzella F, Stoppacciaro A, Mirolo M, Pescarmona E, Vitolo D, Cassano AM, Barsotti P, Nicoletti L, Ruco LP. Systemic lymphadenopathy (LAS) in intravenous drug abusers. Histology, immunohistochemistry and electron microscopy: pathogenic correlations. Histopathology. 9: 1275-93. PMID 3913634 DOI: 10.1111/j.1365-2559.1985.tb02810.x  0.116
1985 Ruco LP, Stoppacciaro A, Pezzella F, Mirolo M, Uccini S, Barsotti P, Cassano AM, Boner AL, Businco L, Di Fazio A. The Omenn's syndrome: histological, immunohistochemical and ultrastructural evidence for a partial T cell deficiency evolving in an abnormal proliferation of T lymphocytes and S-100 +/T-6 + Langerhans-like cells. Virchows Archiv. a, Pathological Anatomy and Histopathology. 407: 69-82. PMID 3925627 DOI: 10.1007/BF00701330  0.112
1999 Hodgson DJ, David KM, Powell M, Holton JL, Pezzella F. Intracranial extracerebral follicular lymphoma mimicking a sphenoid wing meningioma [5] Journal of Neurology Neurosurgery and Psychiatry. 67: 251-252. PMID 10475758 DOI: 10.1136/jnnp.67.2.251  0.111
2020 Qian C, Pezzella F, Lu Z. Foreword for Visualized Cancer Medicine: The era for dynamic visuals is here Visualized Cancer Medicine. 1: E1. DOI: 10.1051/vcm/2020001  0.105
2007 Mager SR, Oomen MHA, Morente MM, Ratcliffe C, Knox K, Kerr DJ, Pezzella F, Riegman PHJ. Standard operating procedure for the collection of fresh frozen tissue samples European Journal of Cancer. 43: 828-834. PMID 17329097 DOI: 10.1016/j.ejca.2007.01.002  0.102
2019 Pezzella F. Mechanisms of resistance to anti-angiogenic treatments. Cancer Drug Resistance (Alhambra, Calif.). 2: 595-607. PMID 35582580 DOI: 10.20517/cdr.2019.39  0.101
2006 Isabelle M, Teodorovic I, Morente MM, Jaminé D, Passioukov A, Lejeune S, Therasse P, Dinjens WNM, Oosterhuis JW, Lam KH, Oomen MHA, Spatz A, Ratcliffe C, Knox K, Mager R, ... ... Pezzella F, et al. TuBaFrost 5: Multifunctional central database application for a European tumor bank European Journal of Cancer. 42: 3103-3109. PMID 17029787 DOI: 10.1016/j.ejca.2006.04.032  0.101
2010 Khan O, Fotheringham S, Wood V, Stimson L, Zhang C, Pezzella F, Duvic M, Kerr DJ, La Thangue NB. HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy. Proceedings of the National Academy of Sciences of the United States of America. 107: 6532-7. PMID 20308564 DOI: 10.1073/pnas.0913912107  0.099
2015 Viollet C, Ragoussis J, Yarchoan R, Pezzella F. 359O A whole genome approach to better understand the link between Kaposi's sarcoma-associated herpesvirus and human cancers Annals of Oncology. 26: ix108. DOI: 10.1093/ANNONC/MDV530.02  0.097
2009 Gramley F, Lorenzen J, Pezzella F, Kettering K, Himmrich E, Plumhans C, Koellensperger E, Munzel T. Hypoxia and myocardial remodeling in human cardiac allografts: a time-course study. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 28: 1119-26. PMID 19782587 DOI: 10.1016/j.healun.2009.05.038  0.095
2000 Kottaridis PD, Ketley N, Peggs K, Chakraverty R, Ralleigh G, Shaw P, Pezzella F, Goldstone AH, Devereux S, Mackinnon S. An unusual case of intrapulmonary granulocytic sarcoma presenting as interstitial pneumonitis following allogeneic bone marrow transplantation for acute myeloid leukaemia and responding to donor lymphocyte infusion. Bone Marrow Transplantation. 24: 807-9. PMID 10516687 DOI: 10.1038/sj.bmt.1701974  0.09
1987 Pezzella M, Pezzella F, Galli C, Macchi B, Verani P, Sorice F, Baroni CD. In situ hybridization of human immunodeficiency virus (HTLV-III) in cryostat sections of lymph nodes of lymphadenopathy syndrome patients. Journal of Medical Virology. 22: 135-42. PMID 3497224 DOI: 10.1002/JMV.1890220204  0.089
2004 Cesario A, Margaritora S, Parodi S, Russo P, La Vecchia C, Apolone G, Galetta D, Pezzella F, Granone P. Networking for excellence in lung cancer: paper vs research work. Lung Cancer (Amsterdam, Netherlands). 43: 363-5. PMID 15165097 DOI: 10.1016/j.lungcan.2003.09.007  0.088
2010 Gatter K, Pezzella F. Diffuse large B-cell lymphoma Diagnostic Histopathology. 16: 69-81. DOI: 10.1016/J.MPDHP.2009.12.002  0.087
2006 Lopez-Guerrero JA, Riegman PHJ, Oosterhuis JW, Lam KH, Oomen MHA, Spatz A, Ratcliffe C, Knox K, Mager R, Kerr D, Pezzella F, van Damme B, van de Vijver M, van Boven H, Morente MM, et al. TuBaFrost 4: Access rules and incentives for a European tumour bank European Journal of Cancer. 42: 2924-2929. PMID 17027256 DOI: 10.1016/j.ejca.2006.04.030  0.087
1989 Pezzella F, Gatter KC, Mason DY. Detection of 14;18 chromosomal translocation in paraffin-embedded lymphoma tissue. Lancet (London, England). 1: 779-80. PMID 2564581 DOI: 10.1016/S0140-6736(89)92594-4  0.086
1989 Pezzella M, Pezzella F, Rapicetta M, Morace G, Macchi B, Sorice F, Baroni CD. HBV and HIV expression in lymph nodes of HIV positive LAS patients: histology and in situ hybridization. Molecular and Cellular Probes. 3: 125-32. PMID 2770752 DOI: 10.1016/0890-8508(89)90023-6  0.084
2014 Midgley R, Love S, Tomlinson I, Johnstone E, Scudder C, Pearson S, Julier P, Domingo E, Church D, Pezzella F, Hu J, Segelov E, Weaver A, Kerr D. Final Results from Quasar2, a Multicentre, International Randomised Phase III Trial of Capecitabine (Cap) +/- Bevacizumab (Bev) in the Adjuvant Setting of Stage Ii/Iii Colorectal Cancer (Crc) Annals of Oncology. 25: v1. DOI: 10.1093/ANNONC/MDU438.10  0.082
1995 Pezzella F, Gatter K. What is the value of bcl-2 protein detection for histopathologists? Histopathology. 26: 89-93. PMID 7713489 DOI: 10.1111/j.1365-2559.1995.tb00628.x  0.08
2003 Prencipe M, Santini M, Casini AR, Pezzella FR, Scaldaferri N, Culasso F. Prevalence of non-dementing cognitive disturbances and their association with vascular risk factors in an elderly population. Journal of Neurology. 250: 907-12. PMID 12928907 DOI: 10.1007/s00415-003-1094-0  0.079
2006 Isabelle M, Teodorovic I, Oosterhuis JW, Riegman PH, Passioukov A, Lejeune S, Therasse P, Dinjens WN, Lam KH, Oomen MH, Spatz A, Ratcliffe C, Knox K, Mager R, Kerr D, ... Pezzella F, et al. Virtual microscopy in virtual tumor banking. Advances in Experimental Medicine and Biology. 587: 75-86. PMID 17163157  0.068
2006 Teodorovic I, Isabelle M, Carbone A, Passioukov A, Lejeune S, Jaminé D, Therasse P, Gloghini A, Dinjens WNM, Lam KH, Oomen MHA, Spatz A, Ratcliffe C, Knox K, Mager R, ... ... Pezzella F, et al. TuBaFrost 6: Virtual microscopy in virtual tumour banking European Journal of Cancer. 42: 3110-3116. PMID 17027253 DOI: 10.1016/j.ejca.2006.04.033  0.065
2010 Gramley F, Lorenzen J, Jedamzik B, Gatter K, Koellensperger E, Munzel T, Pezzella F. Atrial fibrillation is associated with cardiac hypoxia. Cardiovascular Pathology : the Official Journal of the Society For Cardiovascular Pathology. 19: 102-11. PMID 19211267 DOI: 10.1016/j.carpath.2008.11.001  0.061
2020 Sousos N, Buck G, Rodriguez-Meira A, Norfo R, Hamblin A, Pezzella F, Davies J, Hublitz P, Psaila B, Mead AJ. Rapid Emergence of Chronic Lymphocytic Leukemia During JAK2 Inhibitor Therapy in a Patient With Myelofibrosis. Hemasphere. 4: e356. PMID 32647791 DOI: 10.1097/HS9.0000000000000356  0.056
2004 Lorenzen J, Gramley F, Jedamzik B, Rimantas B, Schauerte P, Autschbach R, Gatter K, Pezzella F. Atrial fibrillation, fibrosis, and hypoxia Pathology - Research and Practice. 200: 290. DOI: 10.1016/S0344-0338(04)80536-3  0.055
2004 Pillai G, Pezzella F, Gatter K. 'Follicular' pattern of bone marrow involvement in lymphocyte-predominant Hodgkin's disease. Histopathology. 43: 203-5. PMID 12877742 DOI: 10.1046/j.1365-2559.2003.01634.x  0.05
2017 Hu J, Pepper J, Pezzella F, Gatter K, Jin XY. 130 The convergence and divergence of molecular pathways in lv hypertrophy defined by ecg voltage versus lv mass in patients with aortic stenosis Heart. 103: A98.1-A98. DOI: 10.1136/heartjnl-2017-311726.129  0.037
2017 Hu J, Pepper J, Pezzella F, Gatter K, Jin XY. 128 Genomic insights of ecg strain patten in aortic stenosis: t wave inversion and st-segment depression are underlined by different molecular pathways Heart. 103: A97.1-A97. DOI: 10.1136/heartjnl-2017-311726.127  0.035
2004 Pezzella FR, Di Rezze S, Chianese M, Fabbrini G, Vanacore N, Colosimo C, Meco G. Hedonistic homeostatic dysregulation in Parkinson's disease: a short screening questionnaire. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 24: 205-6. PMID 14598089 DOI: 10.1007/s10072-003-0132-0  0.022
2001 Prencipe M, Casini AR, Ferretti C, Santini M, Pezzella F, Scaldaferri N, Culasso F. Prevalence of headache in an elderly population: attack frequency, disability, and use of medication. Journal of Neurology, Neurosurgery, and Psychiatry. 70: 377-81. PMID 11181862 DOI: 10.1136/JNNP.70.3.377  0.017
2014 Agorreta J, Hu J, Pezzella F. The diverse lives of TRAP1. Oncoscience. 1: 560-1. PMID 25594064 DOI: 10.18632/oncoscience.84  0.01
Hide low-probability matches.